Ligand validation:6JLN

PHO: PHEOPHYTIN A

PHO is a Ligand Of Interest in 6JLN designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6JLN_PHO_D_401	53%	18%	0.183	0.945	1.88	1.8	8	9	0	0	100%	0.4
6JLN_PHO_d_402	48%	17%	0.201	0.944	1.81	1.98	8	8	0	0	100%	0.4
6JLN_PHO_A_408	35%	19%	0.247	0.937	1.83	1.8	8	12	0	0	100%	1
6JLN_PHO_a_411	33%	18%	0.276	0.957	1.94	1.74	9	10	0	0	100%	1
5V2C_PHO_A_608	98%	31%	0.059	0.979	1.52	1.37	8	7	0	0	100%	1
5B66_PHO_A_403	96%	30%	0.068	0.978	1.34	1.59	6	8	0	0	100%	1
7YQ7_PHO_A_407	96%	23%	0.069	0.979	1.7	1.65	7	10	0	0	100%	1
8IRF_PHO_a_407	95%	18%	0.075	0.98	1.83	1.87	8	9	0	0	100%	0.49
8IRI_PHO_a_408	95%	18%	0.076	0.981	1.83	1.87	8	9	0	0	100%	0.49
8IRD_PHO_a_406	95%	18%	0.075	0.979	1.83	1.87	8	9	0	0	100%	0.49

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.